The Board’s Authorisations

The company’s shareholders resolved unanimously on 23 February 2017 to authorize the Board of Directors to decide on one or more directed share issues against consideration. By virtue of this authorization, the number of new shares issued based on the authorization shall not exceed 1,900,000 shares. The authorization is valid for five years from the date it was granted, i.e. until 23 February 2022.

The company’s shareholders resolved unanimously on 23 February 2017 to authorize the Board of Directors to decide on the issue of shares and option rights entitling to shares such that the total number of shares may, pursuant to the authorization, be increased by a maximum of 350,000 shares in the aggregate. The authorization is valid for five years from the date it was granted, i.e. until 23 February 2022.

The company’s shareholders resolved unanimously on 23 February 2017 to authorize the Board of Directors to decide on the acquisition of the company’s own shares with unrestricted equity in one or several tranches. Under the authorization, a maximum of 720,000 shares can be acquired. Shares will be acquired for purposes of the put option in accordance with the terms and conditions of the placing agreement. The authorization is in force until 30 September 2017.

The company’s shareholders resolved unanimously on 23 February 2017 to authorize the Board of Directors to decide on the acquisition of the company’s own shares with unrestricted equity in one or several tranches. Under the authorization, a maximum of 390,000 shares can be acquired. The authorization is valid for eighteen months from the date it was granted, i.e. until 23 August 2018.